
Proficiency Testing - College of American Pathologists
1 天前 · Our comprehensive range of proficiency testing (PT)/external quality assessment (EQA) spans 16 disciplines—giving you the tools you need to verify the accuracy and reliability of your testing process.
Proficiency Testing (PT)/External… | College of American Pathologists
Conducting the College of American Pathologists (CAP) Proficiency Testing (PT)/External Quality Assessment (EQA) for all patient reportable tests demonstrates a commitment to quality improvement and provides an excellent tool for learning and competency assessment.
Proficiency Testing Resources - College of American Pathologists
Find helpful information for the CAP's proficiency testing, or PT programs.
The CAP offers 22 different testing sessions beginning in February and ending in November. You must indicate your top three testing session preferences on the order form. The CAP will make every effort to accommodate your first three preferences; however, an alternate testing session may be issued based on slideset inventory.
2024年9月12日 · We report pathogenic/likely pathogenic and variants of uncertain significance that are present in any gene that fits the phenotype. What CAP PT is available to satisfy alternative assessment requirements for this assay?
For each nonwaived test, there is an evaluation of the test method validation or verification study (accuracy, precision, etc.) signed by the laboratory director, or designee meeting CAP director qualifications, prior to use in patient testing to confirm the acceptability of the data and approve each nonwaived test for clinical use.
Proficiency Testing/External… | College of American Pathologists
The CAP sometimes includes proficiency testing/external quality assessment (PT/EQA) specimens that assess the ability of laboratory staff to make difficult distinctions, to deal with special interferences or circumstances, or that may challenge the routine capabilities of many well-run laboratories.
Qualitative and quantitative testing for the common lymphoid and myeloid genes using either RNA or DNA and minimal residual disease testing for diagnosing and monitoring leukemia tumor burden.
CAP requires that all high complexity testing personnel have earned at least a minimum of an associate degree in a laboratory science or medical technology from an accredited institution. Personnel performing moderately complex testing must have earned a least a high school diploma or equivalent.
• Is there adequate rotation of testing amongst staff? • Does raw data documentation include signed attestation by the director or designee that meets defined regulatory requirements for the complexity of